|Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users|
L Wang, JE Min, E Krebs, E Evans, D Huang, L Liu, YI Hser, B Nosyk
International Journal of Drug Policy 49, 32-40, 2017
|Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996–2013: a modelling study|
B Nosyk, X Zang, JE Min, E Krebs, VD Lima, MJ Milloy, J Shoveller, ...
The lancet HIV 4 (7), e303-e310, 2017
|The costs of crime during and after publicly funded treatment for opioid use disorders: a population‐level study for the state of California|
E Krebs, D Urada, E Evans, D Huang, YI Hser, B Nosyk
Addiction 112 (5), 838-851, 2017
|Cost-effectiveness of publicly funded treatment of opioid use disorder in California|
E Krebs, B Enns, E Evans, D Urada, MD Anglin, RA Rawson, YI Hser, ...
Annals of internal medicine 168 (1), 10-19, 2018
|Dynamics in the costs of criminality among opioid dependent individuals|
E Krebs, T Kerr, J Montaner, E Wood, B Nosyk
Drug and alcohol dependence 144, 193-200, 2014
|The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study|
A Borquez, L Beletsky, B Nosyk, SA Strathdee, A Madrazo, D Abramovitz, ...
The Lancet Public Health 3 (9), e429-e437, 2018
|Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs?|
B Nosyk, E Krebs, O Eyawo, JE Min, R Barrios, JSG Montaner
Current HIV/AIDS Reports 11 (4), 468-478, 2014
|Ending the epidemic in America will not happen if the status quo continues: modeled projections for human immunodeficiency virus incidence in 6 US cities|
B Nosyk, X Zang, E Krebs, JE Min, CN Behrends, C Del Rio, ...
Clinical Infectious Diseases 69 (12), 2195-2198, 2019
|Developing a dynamic HIV transmission model for 6 US cities: an evidence synthesis|
E Krebs, B Enns, L Wang, X Zang, D Panagiotoglou, C Del Rio, ...
PloS one 14 (5), e0217559, 2019
|The Impact of Localized Implementation: Determining the Cost-Effectiveness of HIV Prevention and Care Interventions Across Six United States Cities|
E Krebs, X Zang, B Enns, JE Min, C Behrends, C Del Rio, JC Dombrowski, ...
AIDS 34 (3), 447-458, 2020
|Ending the HIV epidemic in the USA: an economic modelling study in six cities|
B Nosyk, X Zang, E Krebs, B Enns, JE Min, CN Behrends, C Del Rio, ...
The Lancet HIV 7 (7), e491-e503, 2020
|Development and calibration of a dynamic HIV transmission model for 6 US cities|
X Zang, E Krebs, JE Min, A Pandya, BDL Marshall, BR Schackman, ...
Medical Decision Making 40 (1), 3-16, 2020
|The cost-effectiveness of human immunodeficiency virus testing and treatment engagement initiatives in British Columbia, Canada: 2011–2013|
B Nosyk, JE Min, E Krebs, X Zang, M Compton, R Gustafson, R Barrios, ...
Clinical Infectious Diseases 66 (5), 765-777, 2018
|“Ending the Epidemic” Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic|
B Nosyk, E Krebs, X Zang, M Piske, B Enns, JE Min, CN Behrends, ...
Clinical Infectious Diseases 71 (11), 2968-2971, 2020
|Estimating state transitions for opioid use disorders|
E Krebs, JE Min, E Evans, L Li, L Liu, D Huang, D Urada, T Kerr, YI Hser, ...
Medical Decision Making 37 (5), 483-497, 2017
|Increased drug use and the timing of social assistance receipt among people who use illicit drugs|
E Krebs, L Wang, M Olding, K DeBeck, K Hayashi, MJ Milloy, E Wood, ...
Social Science & Medicine 171, 94-102, 2016
|The costs of crime associated with stimulant use in a Canadian setting|
B Enns, E Krebs, K DeBeck, K Hayashi, MJ Milloy, L Richardson, E Wood, ...
Drug and alcohol dependence 180, 304-310, 2017
|Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study|
L Wang, E Krebs, JE Min, WC Mathews, A Nijhawan, C Somboonwit, ...
The Lancet HIV 6 (8), e531-e539, 2019
|Characterizing long-term health related quality of life trajectories of individuals with opioid use disorder|
E Krebs, T Kerr, E Wood, B Nosyk
Journal of substance abuse treatment 67, 30-37, 2016
|Structural design and data requirements for simulation modelling in HIV/AIDS: a narrative review|
X Zang, E Krebs, L Wang, BDL Marshall, R Granich, BR Schackman, ...
PharmacoEconomics 37 (10), 1219-1239, 2019